Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pergolide mesylate salt(LY127809) is a long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential for HEART VALVE DISEASES.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 11,000 | |||
10 mg | 在庫あり | ¥ 15,500 | |||
25 mg | 在庫あり | ¥ 27,000 | |||
50 mg | 在庫あり | ¥ 43,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 12,000 |
説明 | Pergolide mesylate salt(LY127809) is a long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential for HEART VALVE DISEASES. |
別名 | Pergolide mesylate salt, LY127809, Pergolide methanesulfonate |
分子量 | 410.59 |
分子式 | C20H30N2O3S2 |
CAS No. | 66104-23-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (133.95 mM)
H2O: 40 mg/mL (97.4 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pergolide mesylate 66104-23-2 GPCR/G Protein Neuroscience 5-HT Receptor Dopamine Receptor Adrenergic Receptor disease D2-receptor Parkinson's inhibit Inhibitor MDA LY-127809 Pergolide hyperprolactinaemia Pergolide mesylate salt neuroprotection LY127809 D1-receptors Pergolide methanesulfonate LY 127809 Pergolide Mesylate ergoline inhibitor